Endometrial Neoplasms: all 1,347 studies
Page 1 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.
- Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese PopulationsRecruitingNCT07892755
- Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic LesionsRecruitingNCT07883798
- 27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer SurgeryNot yet recruitingNCT07882277Not applicable
- Effect of Weight Management on AMPK Activation in the Adjunctive Treatment of Endometrial CancerNot yet recruitingNCT07879365Not applicable
- Protocol for Non-invasive Gynaecological Surveillance in Lynch SyndromeNot yet recruitingNCT07877779
- MTX-531-001 Phase 1 Study in Advanced Solid TumorsNot yet recruitingNCT07874880Phase 1
- Safety, Efficacy and Quality of Life After Adjuvant Hypofractionated Radiotherapy for Endometrial CancerRecruitingNCT07871838Not applicable
- A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)Not yet recruitingNCT07870278Phase 1
- Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial CancerNot yet recruitingNCT07867002Phase 3
- Two Part (Phase1b/ Phase3) Trial of Subcutaneous Dostarlimab Plus Carboplatin-Paclitaxel in Participants With Primary Advanced or Recurrent Endometrial CancerNot yet recruitingNCT07860450Phase 3
- Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic SurgeryRecruitingNCT07860203Not applicable
- Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial CancerRecruitingNCT07838207
- Imlunestrant/Abemaciclib/Selinexor in Ovarian and EndometrialNot yet recruitingNCT07832227Phase 2
- Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial CancerRecruitingNCT07831902Phase 3
- Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07820358Phase 2
- Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid TumorsNot yet recruitingNCT07815951Phase 1
- Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic CancersNot yet recruitingNCT07815873Not applicable
- A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentNot yet recruitingNCT07814872
- A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid TumorsRecruitingNCT07814248Phase 1
- A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM CancersNot yet recruitingNCT07811297Phase 1/2
- A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast CancersNot yet recruitingNCT07811232Phase 1/2
- ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese CohortRecruitingNCT07808164
- Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticRecruitingNCT07807345Phase 1
- TR115 in ARID1A-Mutated Advanced Solid TumorsNot yet recruitingNCT07793318Phase 2
- Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial CancerNot yet recruitingNCT07781150Phase 2
- Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)RecruitingNCT07779109Not applicable
- Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.RecruitingNCT07755436Phase 1
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune TherapyNot yet recruitingNCT07743541Phase 1/2
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast CancerRecruitingNCT07741968Not applicable
- Development Of An Endometrial Cancer Educational ToolNot yet recruitingNCT07739745Not applicable
- Elemene Liposomes in Endometrial CancerNot yet recruitingNCT07738315Phase 2
- Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial CancerNot yet recruitingNCT07737795Phase 2
- Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial CancerNot yet recruitingNCT07731607Phase 2
- Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C TrialNot yet recruitingNCT07723235Not applicable
- A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid TumorsRecruitingNCT07715747Phase 1
- Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical HyperplasiaNot yet recruitingNCT07714070Phase 2
- Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial CancerRecruitingNCT07702799Not applicable
- Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological MalignanciesNot yet recruitingNCT07702721
- DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCERRecruitingNCT07690540Not applicable
- A Study to Investigate Mocertatug Rezetecan as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)RecruitingNCT07684599Phase 3
- A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and FeasibilityNot yet recruitingNCT07675733Not applicable
- A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.Not yet recruitingNCT07664735Phase 1
- Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation TherapyRecruitingNCT07662824Not applicable
- A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial CancerNot yet recruitingNCT07652515Phase 4
- Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial CancerRecruitingNCT07643012Not applicable
- 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid TumorsNot yet recruitingNCT07639801Not applicable
- Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial CancerNot yet recruitingNCT07634601Phase 2
- Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorNot yet recruitingNCT07631884Phase 2
- An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard TherapyNot yet recruitingNCT07631871Phase 2
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- Fasting InTervention for Endometrial CancerRecruitingNCT07622901Not applicable
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid TumorRecruitingNCT07612891Phase 1/2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D MutationsRecruitingNCT07610798Phase 1/2
- Tirzepatide in the Treatment of Endometrial CancerNot yet recruitingNCT07605247Phase 2
- Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial CancerRecruitingNCT07595224Not applicable
- Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic CancerEnrolling by invitationNCT07594327
- Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy MaintenanceRecruitingNCT07594015Phase 2
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
- MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial CancerRecruitingNCT07584161Not applicable
- Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional LaparoscopyNot yet recruitingNCT07583329
- Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer ProgressionNot yet recruitingNCT07581288
- Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial CancerNot yet recruitingNCT07578649Phase 3
- The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian PopulationRecruitingNCT07558889
- 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
- REal Word aPpLicAtion of Molecular Based Endometrial Cancer ClassificationRecruitingNCT07555665
- Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial CancerRecruitingNCT07527143
- Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid TumorsRecruitingNCT07524322Phase 1
- Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4Not yet recruitingNCT07522697Phase 2
- Adaptive Radiotherapy for Safe HypofractionationNot yet recruitingNCT07516210Phase 2
- MR-guided Adaptive Stereotactic Radiotherapy for Endometrial CancerNot yet recruitingNCT07514325Not applicable
- A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesRecruitingNCT07503808Phase 1
- A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.RecruitingNCT07470853Phase 1
- SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial CancerNot yet recruitingNCT07462663Phase 4
- A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationRecruitingNCT07458347Phase 1
- QLS5132 Combination Therapy in Advanced Solid TumorsNot yet recruitingNCT07453394Phase 1/2
- A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low ExpressionNot yet recruitingNCT07446049Phase 2
- Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsRecruitingNCT07444814Phase 1
- Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy StudyRecruitingNCT07435623
- An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling DeviceNot yet recruitingNCT07429799Not applicable
- A Phase 1 Study of the Safety and Tolerability of CTX-10726RecruitingNCT07419841Phase 1
- Screening and Staging of Benign vs Malignant Pelvic AbnormalitiesRecruitingNCT07407959
- Navigation Intervention for Adolescent and Young Adult Cancer SurvivorsRecruitingNCT07406087Not applicable
- Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal BleedingRecruitingNCT07400835
- Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial CancerRecruitingNCT07397624
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid TumorsRecruitingNCT07383506Phase 1
- Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial CancerRecruitingNCT07382583
- Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical CancerNot yet recruitingNCT07382505
- The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological CancerRecruitingNCT07380698
- Intrauterine Injection of Type III Collage in FST of EC/AEHRecruitingNCT07377734Phase 2
- IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCERNot yet recruitingNCT07374809Not applicable
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsRecruitingNCT07371663Phase 1/2
- Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial CancerNot yet recruitingNCT07369986Phase 2
- Preoperative Risk Stratification in Endometrial Cancer for Tailoring Lymph Node StagingRecruitingNCT07368205
- Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of LifeNot yet recruitingNCT07362147Not applicable
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Signatera Assessment in Early-Stage Endometrial CancerNot yet recruitingNCT07339384Not applicable
- Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsRecruitingNCT07334119Phase 1
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)RecruitingNCT07327489
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3